BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2995968)

  • 1. Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat.
    Rosen CA; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6502-6. PubMed ID: 2995968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.
    Rosen CA; Sodroski JG; Kettman R; Haseltine WA
    J Virol; 1986 Mar; 57(3):738-44. PubMed ID: 3005624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
    Rosen CA; Sodroski JG; Haseltine WA
    Cell; 1985 Jul; 41(3):813-23. PubMed ID: 2988790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression.
    Rosen CA; Park R; Sodroski JG; Haseltine WA
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4919-23. PubMed ID: 3037527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two elements in the bovine leukemia virus long terminal repeat that regulate gene expression.
    Derse D; Casey JW
    Science; 1986 Mar; 231(4744):1437-40. PubMed ID: 3006241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.
    Fujisawa J; Seiki M; Sato M; Yoshida M
    EMBO J; 1986 Apr; 5(4):713-8. PubMed ID: 3011423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription.
    Shimotohno K; Takano M; Teruuchi T; Miwa M
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8112-6. PubMed ID: 3022280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat.
    Brady J; Jeang KT; Duvall J; Khoury G
    J Virol; 1987 Jul; 61(7):2175-81. PubMed ID: 3035218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.
    Fujisawa J; Seiki M; Kiyokawa T; Yoshida M
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2277-81. PubMed ID: 2986109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the transcription control region located within the avian retroviral long terminal repeat.
    Cullen BR; Raymond K; Ju G
    Mol Cell Biol; 1985 Mar; 5(3):438-47. PubMed ID: 2985953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of human T-lymphotropic retroviruses.
    Wong-Staal F; Ratner L; Shaw G; Hahn B; Harper M; Franchini G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4539s-4544s. PubMed ID: 2990683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer.
    Paskalis H; Felber BK; Pavlakis GN
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6558-62. PubMed ID: 3018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U3 sequences from HTLV-I and -II LTRs confer pX protein response to a murine leukemia virus LTR.
    Kitado H; Chen IS; Shah NP; Cann AJ; Shimotohno K; Fan H
    Science; 1987 Feb; 235(4791):901-4. PubMed ID: 3027896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the gene responsible for human T-cell leukaemia virus transcriptional regulation.
    Cann AJ; Rosenblatt JD; Wachsman W; Shah NP; Chen IS
    Nature; 1985 Dec 12-18; 318(6046):571-4. PubMed ID: 2999613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
    Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
    J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.
    Sodroski JG; Rosen CA; Haseltine WA
    Science; 1984 Jul; 225(4660):381-5. PubMed ID: 6330891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.
    Heisig V; Benter T; Josephs SF; Sadaie MR; Okamoto T; Gallo RC; Wong-Staal F
    Haematol Blood Transfus; 1987; 31():423-9. PubMed ID: 3481758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.
    Sherman L; Yaniv A; Lichtman-Pleban H; Tronick SR; Gazit A
    J Virol; 1989 Nov; 63(11):4925-31. PubMed ID: 2552171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus.
    Sodroski J; Rosen C; Goh WC; Haseltine W
    Science; 1985 Jun; 228(4706):1430-4. PubMed ID: 2990028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative molecular biology of HTLV-I and HTLV-II.
    Rosenblatt J; Wachsman W; Shimotohno K; Slamon D; Chen IS
    Princess Takamatsu Symp; 1984; 15():177-85. PubMed ID: 6100637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.